Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin‐converting enzyme

No abstract is available for this paper.

• Publication year

  2003

• Venue

  FEBS Letters

• Publication date

  2003-08-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-5793(03)00825-1PMID 12935891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal structure of the human angiotensin-converting enzyme–lisinopril complex

  2003cited by this paper
• Temperature‐induced selective death of the C‐domain within angiotensin‐converting enzyme molecule

  2002cited by this paper
• Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides.

  2002cited by this paper
• Fluorescence Polarization Studies of Different Forms of Angiotensin-Converting Enzyme

  2001cited by this paper
• RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.

  2001cited by this paper
• Isolation and characterization of the N-domain of bovine angiotensin-converting enzyme.

  2000cited by this paper
• Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.

  2000cited by this paper
• New feature of angiotensin‐converting enzyme: carbohydrate‐recognizing domain

  2000cited by this paper
• RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

  1999cited by this paper
• Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.

  1999cited by this paper
• Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.

  1997cited by this paper
• Limited proteolysis of human kidney angiotensin-converting enzyme and generation of catalytically active N- and C-terminal domains.

  1997cited by this paper
• Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.

  1996cited by this paper
• The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme (*)

  1995cited by this paper
• Peptidyl dipeptidase A: angiotensin I-converting enzyme.

  1995cited by this paper
• Theoretical and practical aspects of proteinase inhibition kinetics.

  1995cited by this paper
• Naturally occurring active N-domain of human angiotensin I-converting enzyme.

  1994cited by this paper
• Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.

  1994cited by this paper
• Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.

  1993cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.

  1992cited by this paper
• Bovine angiotensin converting enzyme cDNA cloning and regulation. Increased expression during endothelial cell growth arrest.

  1992cited by this paper
• Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.

  1991cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

  1991cited by this paper
• Angiotensin-converting enzyme: new concepts concerning its biological role.

  1989cited by this paper
• A procedure for eliminating interferences in the lowry method of protein determination.

  1989cited by this paper
• Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.

  1989cited by this paper
• Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

  1988cited by this paper
• Angiotensin-converting enzyme in the testis and epididymis: differential development and pituitary regulation of isozymes.

  1985cited by this paper
• Generation of a 90 000 molecular weight fragment from human plasma angiotensin-I-converting enzyme by enzymatic or alkaline hydrolysis.

  1983cited by this paper
• A continuous spectrophotometric assay for angiotensin converting enzyme.

  1979cited by this paper
• A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

  1972cited by this paper
• Studies on the angiotensin converting enzyme with different substrates.

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The surface-enhanced Raman scattering method for point-of-care atrial fibrillation diagnostics

  2025cites this paper
• Dimerization and dynamics of angiotensin-I converting enzyme revealed by cryo-EM and MD simulations

  2025cites this paper
• Dimerization and dynamics of human angiotensin-I converting enzyme revealed by cryo-EM and MD simulations

  2025cites this paper
• From Negative to No Cooperativity: Effects of Mutations on Intersubunit Communication within F420H2:NADP+ Oxidoreductase Using Steady-State and Pre-Steady-State Kinetic Methods.

  2025cites this paper
• Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors

  2024cites this paper
• Structural basis for the inhibition of human angiotensin‐1 converting enzyme by fosinoprilat

  2022cites this paper
• Current Trends and Applications of Food Derived Antihypertensive Peptides for the Management of Cardiovascular Disease.

  2022cites this paper
• Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization

  2022cites this paper
• Activity and bioavailability of food protein-derived angiotensin-I-converting enzyme-inhibitory peptides.

  2021cites this paper
• Human angiotensin I‐converting enzyme study by surface‐enhanced Raman spectroscopy

  2021cites this paper
• Interacting cogs in the machinery of the renin angiotensin system

  2019cites this paper
• The Design and Development of a Potent and Selective Novel Diprolyl Derivative That Binds to the N-Domain of Angiotensin-I Converting Enzyme.

  2018cites this paper
• The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?

  2018cites this paper
• QM/MM investigation of the catalytic mechanism of angiotensin-converting enzyme

  2016cites this paper
• Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme

  2016cites this paper
• Evidence of Negative Cooperativity and Half-Site Reactivity within an F420-Dependent Enzyme: Kinetic Analysis of F420H2:NADP(+) Oxidoreductase.

  2016cites this paper
• Mechanistic and kinetic studies on F420H2: NADP+ oxidoreductase from Archeoglobus fulgidus

  2015cites this paper
• Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme

  2015cites this paper
• ACE for all – a molecular perspective

  2014cites this paper
• Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence

  2014cites this paper
• Peptidyl-Dipeptidase A/Angiotensin I-Converting Enzyme

  2013cites this paper
• Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme

  2013cites this paper
• A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme

  2013cites this paper
• The Renin-Angiotensin System and Antihypertensive Drugs in Alzheimer's Disease: Current Standing of the Angiotensin Hypothesis?

  2012cites this paper
• Angiotensin II Binding to Angiotensin I–Converting Enzyme Triggers Calcium Signaling

  2011cites this paper
• Protein-protein interactions of human somatic angiotensin-converting enzyme

  2011cites this paper
• Porcine pulmonary angiotensin I-converting enzyme--biochemical characterization and spatial arrangement of the N- and C-domains by three-dimensional electron microscopic reconstruction.

  2010cites this paper
• Spectroscopic and structural analysis of somatic and N-domain angiotensin I-converting enzyme isoforms from mesangial cells from Wistar and spontaneously hypertensive rats.

  2010cites this paper
• Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

  2010cites this paper
• Signal transduction in CHO cells stably transfected with domain-selective forms of murine ACE

  2010cites this paper
• The brain RAS and Alzheimer's disease.

  2010cites this paper
• A Molecular Basis for the C-Domain Selectivity of Angiotensin-Converting Enzyme

  2009cites this paper
• Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.

  2009cites this paper
• Kinin Receptors and ACE Inhibitors: An Interrelationship

  2009cites this paper
• Activities of angiotensin-converting enzymes (ACE1, ACE2) and inhibition by bioactive lactotripeptides (IPP, VPP, LPP) in porcine ocular tissues

  2009influential citation
• Characteristics of monoclonal antibody binding with the C domain of human angiotensin converting enzyme

  2008cites this paper
• Mapping of conformational mAb epitopes to the C domain of human angiotensin I-converting enzyme.

  2008cites this paper
• Simultaneous Determination of ACE Activity with 2 Substrates Provides Information on the Status of Somatic ACE and Allows Detection of Inhibitors in Human Blood

  2008cites this paper
• Participation of kallikrein-kinin system in different pathologies.

  2008cites this paper
• Angiotensin-Converting Enzyme as a Potential Target for Treatment of Alzheimer's Disease: Inhibition or Activation?

  2008cites this paper
• Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.

  2008cites this paper
• The Structure of Testis Angiotensin-Converting Enzyme ( tACE-g 13 ) in Complex with the Inhibitor RXPA 380 ITAI CHITAPI

  2007cites this paper
• ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

  2007cites this paper
• Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood.

  2007cites this paper
• Evidence for an angiotensin-converting enzyme (ACE) polymorphism in the crayfish Astacus leptodactylus.

  2007cites this paper
• Thermodynamic determination of the binding constants of angiotensin‐converting enzyme inhibitors by a displacement method

  2007cites this paper
• The Structure of Testis Angiotensin-Converting Enzyme (tACE-g13) in Complex with the Inhibitor RXPA380

  2006cites this paper
• Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.

  2006cites this paper
• Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild‐type angiotensin‐converting enzyme

  2006cites this paper
• The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme.

  2006cites this paper
• Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.

  2006cites this paper
• Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.

  2005cites this paper
• Hydrolysis of Angiotensin Peptides by Human Angiotensin I–Converting Enzyme and the Resensitization of B2 Kinin Receptors

  2005cites this paper
• Domain‐Selective Ligand‐Binding Modes and Atomic Level Pharmacophore Refinement in Angiotensin I Converting Enzyme (ACE) Inhibitors

  2005cites this paper
• The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.

  2005cites this paper
• The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae

  2005cites this paper
• Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor*

  2005cites this paper
• A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.

  2004cites this paper
• The central role of angiotensin I-converting enzyme in vertebrate pathophysiology.

  2004cites this paper
• Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.

  2004cites this paper
• Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.

  2004cites this paper